Neuronetics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neuronetics Inc (STIM)
Neuronetics Inc stock price live, this page displays NASDAQ STIM stock exchange data. View the STIM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neuronetics Inc real time stock price chart below.
What Is the Neuronetics Inc Stock Price Today?
The Neuronetics Inc stock price today is 3.300.
What Is the Stock Symbol for Neuronetics Inc?
The stock symbol for Neuronetics Inc is "STIM."
What Stock Exchange Does Neuronetics Inc Trade On?
Neuronetics Inc is listed and trades on the NASDAQ stock exchange.
Is Neuronetics Inc a Good Stock to Buy?
Determining whether Neuronetics Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STIM quote. (ISIN: US64131A1051)
What Is the Neuronetics Inc Stock Price Today?
The Neuronetics Inc stock price today is 3.300.
What Is the Stock Symbol for Neuronetics Inc?
The stock symbol for Neuronetics Inc is "STIM."
What Stock Exchange Does Neuronetics Inc Trade On?
Neuronetics Inc is listed and trades on the NASDAQ stock exchange.
Is Neuronetics Inc a Good Stock to Buy?
Determining whether Neuronetics Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STIM quote. (ISIN: US64131A1051)
Fair Value
An estimate of a Neuronetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.950
3.305
52 wk Range
0.800
3.800
STIM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Neuronetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.9503.305
52 wk Range
0.8003.800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
STIM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Neuronetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
6.000
Upside
+81.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Form 8K Neuronetics Inc For: 11 August- Investing.com
- Neuronetics receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Why is Neuronetics stock surging today?- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.000
(+81.82% Upside)
Neuronetics Inc SWOT Analysis
Merger Momentum | Neuronetics' merger with Greenbrook TMS shows early success, with significant synergies realized and expanded market presence driving growth potential |
Financial Resilience | Despite high Q1 cash burn, Neuronetics projects cash flow breakeven by Q3 2025 and maintains a healthy current ratio of 2.44 |
Strategic Expansion | SPRAVATO rollout and Brain Music Programming initiatives poised to boost revenue, with potential for adolescent indication coverage opening new markets |
Market Outlook | Analysts set $7.00 price target, reflecting optimism in Neuronetics' growth trajectory amid competitive neurohealth solutions landscape |
Neuronetics Inc Earnings Call Summary for Q2/2026
- Neuronetics Q2 loss of 5¢/share beat estimates by 7¢; revenue rose 9.1% to $41.6M, topping forecasts by $1.5M; shares surged 22.58% premarket.
- Gross margin expanded to 61.1% from 46.6% YoY; adjusted EBITDA turned positive at $0.3M vs. -$5.6M prior year, signaling profitability progress.
- Greenbrook clinic revenue jumped 16.8% to $26.9M, while NeuroStar revenue fell 2.7% to $14.7M amid commercial model transition to purchase/lease options.
- FY2026 guidance narrowed to $160-164M revenue; raised gross margin outlook to 48-50%; cut operating expenses to $95-100M from $100-105M prior range.
- Company targets limited net cash use in H2 2026; expanding platform for multiple therapies including TMS, SPRAVATO, and future psychedelic treatments.
Last Updated: 11/08/2026, 14:22
Read Full TranscriptEarnings
Latest Release
Aug 11, 2026
EPS / Forecast
-0.05 / -0.12
Revenue / Forecast
41.57M / 40.11M
Compare STIM to Peers and Sector
Metrics to compare | STIM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTIMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.3x | −2.1x | −0.4x | |
PEG Ratio | −0.15 | −0.18 | 0.00 | |
Price/Book | 14.1x | 5.0x | 2.6x | |
Price / LTM Sales | 1.6x | 3.6x | 3.1x | |
Upside (Analyst Target) | 81.8% | 25.4% | 47.9% | |
Fair Value Upside | Unlock | −9.2% | 6.3% | Unlock |
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Neuronetics (STIM) Stock Price Today?
The Neuronetics stock price today is 3.300 USD.
What Stock Exchange Does Neuronetics Trade On?
Neuronetics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Neuronetics?
The stock symbol for Neuronetics is "STIM."
What Is the Neuronetics Market Cap?
As of today, Neuronetics market cap is 251.450M USD.
What Is Neuronetics's Earnings Per Share (TTM)?
The Neuronetics EPS (TTM) is -0.437.
When Is the Next Neuronetics Earnings Date?
Neuronetics will release its next earnings report on Nov 10, 2026.
From a Technical Analysis Perspective, Is STIM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Neuronetics Stock Split?
Neuronetics has split 0 times.
How Many Employees Does Neuronetics Have?
Neuronetics has 658 employees.
What is the current trading status of Neuronetics (STIM)?
As of Aug 17, 2026, Neuronetics (STIM) is trading at a price of 3.300 USD, with a previous close of 3.300 USD. The stock has fluctuated within a day range of 2.950 USD to 3.305 USD, while its 52-week range spans from 0.800 USD to 3.800 USD.
What Is Neuronetics (STIM) Price Target According to Analysts?
The average 12-month price target for Neuronetics is 6.000 USD, with a high estimate of 7 USD and a low estimate of 5 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +81.82% Upside potential.
What Is the STIM Premarket Price?
STIM's last pre-market stock price is 3.380 USD. The pre-market share volume is 1,910.000, and the stock has decreased by 0.080, or 2.420%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.